ask="45.67"
ask_size="500"
average_daily_volume="1024250"
bid="40.51"
bid_size="2000"
book_value="4.05"
change="-1.97"
change_from_200_day_moving_average="-6.51"
change_from_50_day_moving_average="-2.75"
change_from_52_week_high="-14.51"
change_From_52_week_low="9.39"
change_in_percent="-4.62%"
close="40.64"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="42.57"
high_52_weeks="55.15"
last_trade_date="1/11/2017"
last_trade_price="40.64"
last_trade_size="100"
last_trade_time="4:00pm"
low="40.00"
low_52_weeks="31.25"
market_capitalization="3.53B"
moving_average_200_day="47.15"
moving_average_50_day="43.39"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="42.41"
pe_ratio="N/A"
peg_ratio="0.72"
percent_change_from_200_day_moving_average="-13.81%"
percent_change_from_50_day_moving_average="-6.34%"
percent_change_from_52_week_high="-26.31%"
percent_change_from_52_week_low="+30.05%"
previous_close="42.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.53"
price_per_sales="246.77"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="1621158"
weeks_range_52="31.25 - 55.15"
